Evaluation of a Personcentered Internet-based CBT Program for Stress, Anxiety and Depressive Symptoms in Patients With Cardiovascular Disease

NCT ID: NCT04726722

Last Updated: 2025-11-24

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

215 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-13

Study Completion Date

2025-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate a nine-week adaptable and person-centred I-CBT program that can be directed towards stress, anxiety and depressive symptoms in persons with CVD.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

All patients diagnosed as CVD (i.e. diagnosis Ischemia (ICD-code I20., I25.), Heart Failure (ICD-code I50., I42.) or Arrhythmia (ICD-code I48, I49, DF016) and who received care in the last 12 months at hospitals in the south-east of Sweden will be contacted by letter with information about the study.

Participants who are interested are invited to visit our website for more information, registration and provision of informed consent. After registration, participants will respond to questions about demographics, medical history, stress, anxiety and depressive symptoms on the website. Inclusion or exclusion will be assessed by a group consisting of a psychologist, cardiology specialist nurse and a psychiatry specialist nurse.

Before final inclusion and randomization eligible participants will be contacted for a telephone interview held by the study nurses.

Included (n=400) participants will, on our website (www.xxxxxx), complete the baseline study questionnaires and then be randomized according to a 2 x2 factorial design.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cardiovascular Disease Psychological Distress

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

2 x 2
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Design of the CBT treatment content

Patient determined CBT content (i.e. person-centered) vs. therapist determined I-CBT content

Group Type EXPERIMENTAL

internet-based cognitive behavioral theraphy

Intervention Type BEHAVIORAL

When determining the content of the I-CBT program, the participants and therapist will be allowed to choose from a library of treatment modules.

Therapist controlled support and feedback are given weekly and in a structured manner. Participants will be able to contact the therapist when support and feedback is desired

Control of support and feedback

Patient-controlled support and feedback (person-centred) vs. therapist -controlled.

Group Type EXPERIMENTAL

internet-based cognitive behavioral theraphy

Intervention Type BEHAVIORAL

When determining the content of the I-CBT program, the participants and therapist will be allowed to choose from a library of treatment modules.

Therapist controlled support and feedback are given weekly and in a structured manner. Participants will be able to contact the therapist when support and feedback is desired

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

internet-based cognitive behavioral theraphy

When determining the content of the I-CBT program, the participants and therapist will be allowed to choose from a library of treatment modules.

Therapist controlled support and feedback are given weekly and in a structured manner. Participants will be able to contact the therapist when support and feedback is desired

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* age 18 years and above
* treatment for cardiovascular disease (CVD) according to European Society of Cardiology guidelines
* stable CVD (New York Heart Association class I-III) and not having been hospitalised for CVD in in the last four weeks.
* stress (Perceived Stress Scale (PSS)-10\>13 points) and/or
* anxiety (i.e. General Anxiety Disorder Scale (GAD) ≥5 points) and/or
* depressive symptoms (Patient Health Questionnaire-9 28 (PHQ-9) \> 5 points)

Exclusion Criteria

* severe CVD (New York Heart Association classification IV) or another severe chronic life-threatening disease
* severe stress, anxiety or depression assessed as requiring acute treatment
* not being able to dedicate 3-4 hours per week to participate in the program
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Linkoeping

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Peter Johansson

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Johansson, Ph.D

Role: PRINCIPAL_INVESTIGATOR

Department of Health, Medicine and Caring Sciences, Linkoping University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Peter Johansson

Norrköping, Linköpings Universitet, Sweden

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Sweden

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2020-00935

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.